These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15230751)

  • 21. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Ma J; Chen LH; Xia YF; Shi YS
    Radiother Oncol; 2005 May; 75(2):197-203. PubMed ID: 15876464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
    Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy.
    Kodaira T; Tomita N; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Fuwa N
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1129-34. PubMed ID: 18922651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI
    Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
    Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
    Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
    Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.
    Isobe K; Uno T; Kawakami H; Ueno N; Aruga T; Yasuda S; Hanazawa T; Okamoto Y; Ito H; Shigematsu N
    Jpn J Clin Oncol; 2005 Mar; 35(3):116-20. PubMed ID: 15741300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.
    Seung S; Bae J; Solhjem M; Bader S; Gannett D; Hansen EK; Louie J; Underhill K; Cha C
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1075-81. PubMed ID: 18486355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer.
    Selvaraj RN; Beriwal S; Pourarian RJ; Lalonde RJ; Chen A; Mehta K; Brunner G; Wagner KA; Yue NJ; Huq SM; Heron DE
    Med Dosim; 2007; 32(4):299-304. PubMed ID: 17980832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Chua DT; Sham JS; Leung LH; Au GK
    Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy.
    Laskar S; Bahl G; Muckaden M; Pai SK; Gupta T; Banavali S; Arora B; Sharma D; Kurkure PA; Ramadwar M; Viswanathan S; Rangarajan V; Qureshi S; Deshpande DD; Shrivastava SK; Dinshaw KA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):728-36. PubMed ID: 18374512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; Cattaneo GM; Chiara A; De Martin E; Di Muzio N; Fazio F; Calandrino R
    Strahlenther Onkol; 2007 Sep; 183(9):497-505. PubMed ID: 17762924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.